RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • July 5th, 2012 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 5th, 2012 Company IndustrySTELLAR BIOTECHNOLOGIES, Inc., a corporation duly organized under and pursuant to the laws of California, USA, and having its principal offices at 321E. Hueneme Rd, #170 Port Hueneme, CA 93041, USA, (hereinafter referred to as “STELLAR”)
MANUFACTURING AND SUPPLY AGREEMENT Stellar Biotechnologies, Inc. and Life Diagnostics, Inc.Manufacturing and Supply Agreement • July 5th, 2012 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 5th, 2012 Company IndustryLife Diagnostics, Inc., a Pennsylvania corporation with administrative offices at 906 Old Fern Hill Road, West Chester, PA 19380 (“LIFE DX”) and Stellar Biotechnologies, Inc., a Canadian corporation having a place of business at 332 E. Scott Street, Port Hueneme, CA 93041 (”STELLAR”), together “The Parties”, agree as follows:
ContractSupply Agreement • July 5th, 2012 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 5th, 2012 Company Industry Jurisdiction[ * ] INDICATES CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
AGREEMENT FOR MARKETING AND SALE OF CHEMICALSMarketing and Sale Agreement • July 5th, 2012 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations • Wisconsin
Contract Type FiledJuly 5th, 2012 Company Industry JurisdictionStellar Biotechnologies; a company incorporated under the law of the State of California whose principal place of business is at 332 Scott Street, PMB 170, Port Hueneme, CA 93041 (“Stellar”); and
ContractSupply Agreement • July 5th, 2012 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 5th, 2012 Company Industry Jurisdiction[ * ] INDICATES CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.